Legal uncertainties and challenges with interoperability and usability have kept many healthcare providers from embracing systems for electronic prescribing of controlled substances.
Scott Mace, for HealthLeaders Media , June 9, 2015
Patient data, a longitudinal patient record, and patient identifiers remain valid goals of healthcare reform, despite unhappiness with meaningful use.
- The new generation of alerts can be improved from massive amounts of data already collected in the EHR. Deep understanding of disease and pharmacological effects of treatment are essential to creating smart rules for alerts, he says.
- Ambient systems need to recognize patient treatment processes to deliver alerts to the right person at the right time in the workflow process.
- Real-time feedback to bedside providers is essential, Herasevich says. Alert systems should constantly analyze responses to alerts and adjust accordingly.
- The fourth step in rules development is clinical validation against a gold standard, which requires clinical research similar as the study of new drug, he says.
- Regulatory approval of complex smart rules should be the last, fifth step to ensure efficiency, safety and support any commercial claims.